Treatment Registry
TR-0246 ActiveRecorded September 2026

Compounded tirzepatide

Sold by MaxLife · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$120

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Starting price · recorded initial monthly payment$120

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price

“Tirzepatide Two receptors · MaxLife patients have lost up to 53.6 lbs in 52 weeks Starting at $120/mo”

Per month$120Charged today$120
Price sources
Visit MaxLife

We earn nothing from this link. It opens MaxLife's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberBoth
CancellationNo. MaxLife programs do not require a long-term contract. We offer different billing periods, and you may cancel anytime by submitting a cancellation notice at least 30 days before your next billing period begins. Please note that medication costs are not refundable.

Not yet checked: pharmacy, membership and consult fee.

Recorded from maxlife.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — All facts for this candidate came from a single, unusually thorough homepage FAQ block; no separate pricing or terms page was linked in the fetched output.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0246
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from MaxLife

All MaxLife programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). MaxLife — compounded tirzepatide (TR-0246). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0246

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.